Compare Johnson & Johnson (JNJ) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Williams Companies Inc — how do they compare? Johnson & Johnson trades at $249.28 (market cap $598.96B), while Williams Companies Inc trades at $73.32 (market cap $90.70B). The key difference: Johnson & Johnson is far larger — about 6.6× Williams Companies Inc's market cap, and Williams Companies Inc pays the higher dividend (2.83%). Which is the better fit depends on your goals.
| JNJ | WMB | |
|---|---|---|
Market Cap | $598.96B | $90.70B |
Volume | 6,156,228 | — |
Sector | Health | Energy |
52-Week High | $267.24 | $79.40 |
52-Week Low | $164.36 | $56.51 |
Enterprise Value | $631.90B | $120.08B |
Dividend Yield | 2.15% | 2.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
WMB trades at $74.57, up 1.62% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $11.95B in 2025 with a net income margin of 23.4% and recently secured a $5.34 billion Blackstone-led investment for power projects. Analyst consensus is strongly bullish with a $86.00 price target and 79% buy ratings.
The outlook is supported by strategic investments in energy infrastructure and stable cash flows, but risks include high debt levels and sensitivity to natural gas prices. The stock offers a dividend yield and growth potential from LNG expansion, though recent earnings misses warrant monitoring execution on new projects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
